ESMO Congress 2026: participation from Ireland
This page highlights sessions and posters at ESMO Congress 2026 featuring investigators, clinicians, researchers and collaborators based in Ireland. The list is a work in progress and will be updated as we identify further contributions. If you are involved in a session or have co-authored research being presented that is not yet listed, please get in touch so we can add it. You can email comms@cancertrials.ie
We warmly encourage delegates to attend and support colleagues wherever possible. You can find timings and locations for each session by following the links below.
Oral presentations and session roles
Gerard Hanna (Dublin, Ireland)
Maeve A. Lowery (Dublin, Ireland)
Patrick Forde (Dublin, Ireland)
Anne-Marie Baird (Dublin, Ireland)
Josephine Hegarty (Cork, Ireland)
Mark Dornan (Belfast, United Kingdom)
Ciara Nic Giolla Chomhaill (Galway, Ireland)
Brid O’ Riordan (Dublin, Ireland)
Research presented at the Congress
Paul J. Kelly (Cork, Ireland; co-author)
Janice M. Walshe (Dublin, Ireland; co-author)
Catherine M. Kelly (Dublin, Ireland; co-author)
Raymond McDermott (Dublin, Ireland; co-author)
Posters
Starting Friday, 23 October, paper posters will be displayed in Hall 5 for one full day each. Poster sessions will take place from 15:15 to 16:00 on Friday and from 12:00 to 12:45 on Saturday, Sunday and Monday. Display days are indicated below. ePosters will be available onsite on searchable screens in Hall 5 and via the ESMO Virtual Congress Platform.
Poster | Display |
|---|---|
4297P – Transcriptionally distinct tumour lineages identified by single-cell trajectory analysis of metastatic small cell lung cancer. Anne-Marie Baird (Dublin, Ireland) | Friday |
4430P – ETOP Lungscope: Concordance of MTAP expression between Primary NSCLC and Matched Metastases by IHC. Stephen P. Finn (Dublin, Ireland) | Friday |
721P – Impact of WHO 2016/2021 Reclassification on Glioma Subtype Incidence: A SEER Registry Analysis (2000-2023). Alexandru M. Zob (Dublin, Ireland) | Saturday |
1155P – Risk modelling identifies additional germline pathogenic variants beyond phenotype-based mainstream testing criteria in breast cancer: a real-world cohort study. Karolina Weiner-Gorzel (Dublin, Ireland) | Sunday |
2952P – Outcomes of national screening for gastric cancer in CDH1-mutated patients with exploratory fragmentomic analysis. Alice Talbot (Dublin, Ireland) | Sunday |
82eP – An Evaluation of Disparities of Care regarding Nationality in Breast Cancer in Ireland. Kate E. Coakley (Cork, Ireland) | ePoster |
933eP – The association of Escherichia coli genotoxic metabolite colibactin with colorectal cancer risk and progression from dysplasia to carcinoma – a systematic review and meta-analysis. Shona Reid (Limerick, Ireland) | ePoster |
1086eP – Antibody-drug conjugates in heavily pre-treated gynaecological malignancies: a single-centre phase I experience. Calvin Flynn (Dublin, Ireland) | ePoster |
1194eP – Beyond BRCA: more than half of germline pathogenic variants in breast and gynaecological cancers occur in non-BRCA genes in a real-world oncology mainstreaming cohort. Karolina Weiner-Gorzel (Dublin, Ireland) | ePoster |
1232eP – Outcomes and adjuvant treatment patterns in node-positive penile squamous cell carcinoma following national centralisation in Ireland. Dearbhail Ni Chaoimh (Dublin, Ireland) | ePoster |
1381eP – Universal MMR Testing in Endometrial Cancer: Real-World Adherence to the Manchester Consensus Pathway and Implementation Gaps. Hebatalla A. Ismail (Dublin, Ireland) | ePoster |
2442eP – Role of Oncologists in Diagnostics and Monitoring of Neuroendocrine Tumor (NET) Patients Globally and in Europe. Mark McDonnell (Lucan, Ireland) | ePoster |
3122eP – Bereavement Care Practices in Irish Cancer Services: A National Survey of Consultants. Kevin Dunne (Limerick, Ireland) | ePoster |
3433eP – Evolving Patterns of Diagnosis, Management, and Outcomes in Non-Small Cell Lung Cancer (NSCLC): A National Registry Analysis in Ireland (1994-2020). Meredith Norton (Dublin, Ireland) | ePoster |
3519eP – Prevalence and correlates of Fear of Cancer Recurrence amongst adult cancer survivors. Catherine M. O’Brien (Dublin, Ireland) | ePoster |
4068eP – A Systematic Review and Pooled Analysis of 5FU induced Leukoencephalopathy. Nicole Yong (Dublin, Ireland) | ePoster |
4571eP – Combined KRAS and PI3K inhibition enhances anti-proliferative activity in KRAS G12D- and PIK3CA-co-mutant colorectal cancer models. Calvin Flynn (Dublin, Ireland) | ePoster |
4637eTiP – A prospective translational study, investigating the association of gut microbiome diversity with pathological complete response after neoadjuvant treatment in early-stage breast, rectal and esophageal cancer. Ruth Hutch (Dublin, Ireland) | ePoster |
4638eTiP – Proteomic analysis of extracellular vesicles in rectal cancer patients during total neoadjuvant treatment. Rachel Clarke (Dublin, Ireland) | ePoster |
4880eP – Patient Experience Using an Electronic Family History Collection Tool in an Irish Cancer Genetics Clinic. Niamh Ryan (Dublin, Ireland) | ePoster |
4969eTiP – A prospective feasibility study to evaluate Chemokeyp patient safety software in a single centre. Paula Lynch (Dublin, Ireland) | ePoster |
148P – Advancing federated sharing of cancer clinical and genomic data across Europe: The 1+Million Genomes Cancer Working Group Minimal Set for Cancer. Abhishek Nayak (Limerick, Ireland)(Monday)
| 2474P – Identification of a novel cluster of patients with prostate cancer in Japan with improved quality of life – results of the largest international digital survey of people affected by prostate cancer. Joe O’Sullivan (Belfast, United Kingdom) | (Saturday) |
| 2025TiP – ARTEMIDE-Lung04: A phase III, randomised, double-blind, global study of rilvegostomig or pembrolizumab monotherapy as first-line (1L) treatment for patients with metastatic non-small cell lung cancer (mNSCLC) and programmed cell death ligand-1 (PD-L1) expression ≥50%. Jarushka Naidoo (Dublin, Ireland) | (Saturday) |
| 1166P – Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/GOG-3024/ENGOT-cx8 study. Dearbhaile C. Collins (Cork, Ireland) | (Saturday) |
| 2483P – PCPro, plasma lipid biomarker, in metastatic hormone-sensitive prostate cancer (mHSPC): from research to clinical implementation in the ENZAMET trial (ANZUP 1304). Raymond McDermott (Dublin, Ireland) | (Saturday) |
| 2519TiP – EORTC GUCG 2238 De-escalate: A pragmatic trial to revisit intermittent androgen-deprivation therapy in metastatic hormone-naïve prostate cancer in the era of new AR pathway inhibitors. Raymond McDermott (Dublin, Ireland) | (Saturday) |
| 3149P – A Pan-European survey of irAEs: Clinical practice and models-of-care in 32 countries. Maggie L. O’Connor (Dublin, Ireland) | (Saturday) |
| 2308P – The triple planetary crisis: Implications for Ireland’s next national cancer strategy. Hailey K. Carroll (Dublin, Ireland) | (Sunday) |
| 2857P – Vasomotor symptom alleviation through acupuncture in patients with prostate cancer: results from the VASAPRO pilot study. Zain Ul Abedin (Cork, Ireland) | (Sunday) |
| 2363P – Modelling the cost of BRCA testing strategies in ovarian cancer: Integrated vs reflex testing. Ciara S. McNevin (Dublin, Ireland) | (Sunday) |
| 421TiP –OPTImaL: Optimisation of treatment for patients with low stage triple-negative breast cancer with high stromal tumor-infiltrating lymphocytes. Adrianne L. Rolfes (Amsterdam, Netherlands) | (Monday) |
| 2994P – Insights into rare cancers: Characterizing the genomic landscape of anaplastic thyroid cancer. Ruth Hutch (Limerick, Ireland) | (Monday) |
| 376P – Oncotype-DX recurrence score (ODX RS)-guided management and long-term clinical outcomes of Irish women with node-negative (N0), oestrogen-positive (ER+), early breast cancer (EBC). Hailey K. Carroll (Dublin, Ireland) | (Monday) |
| 2048eP – Real-world survival outcomes in advanced non-small cell lung cancer (NSCLC) with driver mutations: A study from Ireland South region. Julie Twomey (Cork, Ireland) | (ePoster) |
| 427eP – Analysis of diagnostic efficacy of tomosynthesis and mammogram in male breast cancer. Abeera Mehmood (Cork, Ireland) | (ePoster) |
| 892eP – Emerging trends of early-onset colorectal cancer observed in an Irish cohort. Alice Talbot (Dublin, Ireland) | (ePoster) |
| 107eP – Safety of ivosidenib in patients with mIDH1 CCA: Updated results from the phase IIIb ProvIDHe study. Raymond McDermott (Dublin, Ireland) | (ePoster) |